Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
TELA
TELA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
TELA News
BDX Faces Monopoly Allegations in U.S. Hernia Mesh Market, Impacting Patient Choices
Dec 23 2025
Benzinga
Becton, Dickinson Faces Allegations of Stifling Competition in Hernia Mesh Industry
Dec 22 2025
SeekingAlpha
TELA Bio Grants 3,600 Restricted Stock Units to New Employees
Dec 12 2025
Globenewswire
TELA Bio Grants 3,600 Restricted Stock Units to New Employees
Dec 12 2025
Newsfilter
Alphabet Set to Surge Over 12%? Check Out 10 Leading Analyst Predictions for Tuesday
Nov 18 2025
Benzinga
Canaccord Genuity Keeps Buy Rating on TELA Bio, Reduces Price Target to $4
Nov 18 2025
Benzinga
NOTV and APLT Top After-Hours Biotech Gains; ALMS, TELA, CORT, and BRTX Also Show Progress
Nov 18 2025
NASDAQ.COM
TELA Bio Unveils Inducement Grants in Accordance with Nasdaq Listing Rule 5635(c)(4)
Nov 17 2025
Newsfilter
Analysts Downgrade TELA Bio Forecasts Following Q3 Earnings Report
Nov 14 2025
Benzinga
Piper Sandler Maintains Neutral Rating on TELA Bio, Reduces Price Target to $1.25
Nov 14 2025
Benzinga
TELA Bio Sets Pricing for $13.0 Million Underwritten Registered Direct Offering of Common Stock and Pre-Funded Warrants
Nov 13 2025
Newsfilter
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
Jun 03 2025
Newsfilter
TELA Bio Appoints Jeffrey Blizard as President
Jun 02 2025
Newsfilter
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference
May 22 2025
Newsfilter
TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates
May 08 2025
NASDAQ.COM
TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery
Mar 31 2025
Newsfilter
Show More News
